Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: An in vivo and in vitro study [5]

Blood

Volumn 108, Issue 2, 2006, Pages 773-774

  Illa, Isabel ^a   De La Torre, Carolina ^b   Rojas Garcia, Ricardo ^b   Altes, Antoni ^b   Blesa, Rafael ^b   Sierra, Jordi ^b   Gallardo, Eduard ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN G; MELPHALAN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL CULTURE; CELL PROLIFERATION; COMPUTER PROGRAM; CONVALESCENCE; DISEASE SEVERITY; DOWN REGULATION; FIBROBLAST; GROWTH INHIBITION; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SCLEROMYXEDEMA; SKIN BIOPSY; SKIN DEFECT; SPIKE; SYMPTOMATOLOGY; UPREGULATION;

EID: 33745954517     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-01-0186     Document Type: Letter

References (10)

1. Feasel AM, Donato ML, Duvic M. Complete remission of scleromyxedema following autologous stem cell transplantation. Arch Dermatol. 2001;137:1071-1072.
2. Lacy MQ, Hogan WJ, Gertz MA, et al. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol. 2005;141:1277-1282.
3. Donato ML, Feasel AM, Weber DM, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood. 2006;107:463-466.
4. Ferrarini M, Helfrich DJ, Walker ER, Medsger TA Jr, Whiteside TL. Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts. J Rheumatol. 1989;16:837-841.
5. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science. 1978;199:545-547.
6. Safford SE, Oberley TD, Urano M, St Clair DK. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 1994;54:4261-4265.
7. Frank S, Kampfer H, Podda M, Kaufmann R, Pfeilschifter J. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem J. 2000;346:719-728.
8. Rowlands DC, Williams A, Jones NA, et al. Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages. Lab Invest. 1995;72:100-113.
9. Schluter K, Jockusch BM, Rothkegel M. Profilins as regulators of actin dynamics. Biochim Biophys Acta. 1997;1359:97-109.
10. Mitchell RA. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal. 2004;16:13-19.